Skip to main content

Exclusive Breastfeeding Drives AMPK-Dependent Thermogenic Memory in BAT and Promotes Long-Term Metabolic Benefits in Offspring.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)2025-12-19PubMed
Total: 85.5Rigor: 9Innovation: 9Journal: 8Clinical: 7

Summary

In mice, exclusive breastfeeding imprints a durable AMPK- and α-ketoglutarate–dependent thermogenic program in brown adipose tissue via breast milk EV miR-125a-5p targeting HIF1AN. This thermogenic memory confers long-term resistance to diet-induced obesity and glucose intolerance; AMPK inhibition abrogates these benefits and αKG supplementation rescues impaired BAT in mixed-fed mice.

Key Findings

  • Mixed formula feeding impaired BAT morphology, mitochondria, and thermogenesis, increasing adiposity and glucose intolerance under HFD.
  • Exclusive breastfeeding preserved BAT thermogenic function for up to 12 weeks post-transplant and sustained AMPK activation.
  • Breast milk EV miR-125a-5p targeted HIF1AN, enhancing AMPK signaling; AMPK inhibition abolished benefits.
  • AMPK-induced α-ketoglutarate was essential for BAT thermogenesis; αKG supplementation rescued BAT defects in mixed-fed mice.

Clinical Implications

Reinforces recommendations for exclusive breastfeeding as a metabolic preventive strategy and nominates AMPK/αKG and milk EV miRNAs as translational targets for obesity and insulin resistance prevention.

Why It Matters

This study uncovers a previously unrecognized, mechanistic link between exclusive breastfeeding and long-term metabolic health through a defined HIF1AN/AMPK/αKG axis in BAT. It provides actionable molecular targets (AMPK, αKG, EV-miR-125a-5p) for metabolic programming.

Limitations

  • Preclinical mouse model; human generalizability and dose-response of EV miRNAs remain untested.
  • Sample sizes and sex-specific effects are not detailed in the abstract; long-term safety of αKG supplementation requires evaluation.

Future Directions

Prospective human studies to test breastfeeding-associated BAT programming markers (AMPK/αKG signatures, EV miR-125a-5p) and interventional trials targeting AMPK/αKG pathways for metabolic disease prevention.

Study Information

Study Type
Cohort
Research Domain
Pathophysiology/Prevention
Evidence Level
III - Preclinical mechanistic experiments in mice with group comparisons and interventions.
Study Design
OTHER